3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
9
Carcinoma, Renal Cell
4
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
3
Kidney Neoplasms
3
Lymphoma
2
Leukemia
2
Skin Neoplasms
1
Sezary Syndrome
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precancerous Conditions
1
Ovarian Neoplasms
1
Osteosarcoma
1
Neurofibromatosis 1
1
Neurofibroma, Plexiform
1
Neurofibroma
1
Neoplasms
1
Neoplasm Metastasis
1
Mycosis Fungoides
1
Lymphoma, T-Cell, Cutaneous
1
Leukemia-Lymphoma, Adult T-Cell
1
HTLV-I Infections
1
Glioma
1
Fallopian Tube Neoplasms
1
Cholangiocarcinoma
1
Carcinoma, Squamous Cell
1
Carcinoma, Hepatocellular
1
Carcinoma
1
Brain Neoplasms
1
Astrocytoma
1
Interventions
Radiotherapy
2
Pyridoxine
2
Etoposide
2
Cytarabine
2
Cyclophosphamide
2
sodium thiosulfate
1
pegfilgrastim
1
pegaspargase
1
etoposide phosphate
1
Vincristine
1
Triptorelin Pamoate
1
Rituximab
1
Prednisolone
1
Methylprednisolone
1
Methotrexate
1
Mercaptopurine
1
Leucovorin
1
Hydrocortisone
1
Granulocyte Colony-Stimulating Factor
1
Filgrastim
1
Doxorubicin
1
Dexrazoxane
1
Dexamethasone
1
Celecoxib
1
Carboplatin
1
Capecitabine
1
Asparaginase
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Drug-Related Side Effects and Adverse Reactions
×
peginterferon alfa-2b
×
Clear all
No trials found.